| Project/Area Number |
11670840
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Dermatology
|
|---|
| Research Institution | Kagoshima University |
|---|
Principal Investigator |
KANEKURA Takuro Faculty of Medicine, Kagoshima University, Associate Professor, 医学部, 助教授 (70177509)
|
|---|
| Project Period (FY) |
1999 – 2000
|
| Project Status |
Completed (Fiscal Year 2000)
|
| Budget Amount *help |
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2000: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 1999: ¥2,100,000 (Direct Cost: ¥2,100,000)
|
|---|
| Keywords | skin cancer / cyclooxygenase-2 / retinoic acid / antioxydant / cancer chemoprevention / アラキドン酸カスケード / サイクロオキシゲナーゼ |
|---|
| Research Abstract |
The expression of COX-2 and prostaglandin (PG) E_2 production were investigated in two human skin epidermal cancer cell lines ; cutaneous squamous cell carcinoma, HSC-5 and eccrine carcinoma, EcCa. Both COX-2 expression and PGE_2 production were significantly enhanced in cancer cell lines compared to the nontumorigenic human keratinocyte cell line, HaCaT.In order to determine the role of COX-2 in the proliferation of HSC-5 and EcCa, the growth of untreated cells and cells transfected with COX-2 antisense oligonucleotide was compared by MTT proliferation assay. Transfection with the antisense oligonucleotide suppressed COX-2 protein expression and significantly inhibited cell growth. The effect of a selective inhibitor of COX-2, NS398, was compared with the effect of the antisense oligonucleotide. COX- 2 expression was unchanged by NS398 treatment, whereas NS398 inhibited cell growth to a certain extent. The degree of growth inhibition was greater with the antisense oligonucleotide than with NS398. Based on these findings, we searched for agents which suppress COX-2 expression and examine their effects on cell growth. Since retinoids and antioxidants have been used for chemoprevention of cancers in several tissues, the effects of these agents on COX-2 expression and PGE_2 biosynthesis in skin squamous carcinoma cells were investigated. Treatment with a retinoid [9-cis- retinoic acid (9-cis-RA)] or an antioxidant [pyrrolidinedithiocarbamate (PDTC)] suppressed COX-2 expression and PGE_2 biosynthesis in a concentration-dependent manner. Cell growth was significantly inhibited by 9-cis-RA and PDTC.These results suggest that 9-cis-RA and PDTC may be useful in preventing skin cancer growth and that COX-2 is involved in their protective effects on skin carcinogenesis.
|
